Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, 6 month trial, of immediate release methylphenidate (MPH-IR) for
children with ADHD aimed at assessing whether the observable behavioral changes seen during
treatment are associated with potentially more stable underlying modifications in brain
functioning (resting-state functional connectivity). Additionally, we will also be looking at
treatment effects on neuropsychological processes and reading skills. This information will
contribute to the first Brazilian study assessing the cost-effectiveness of the treatment of
ADHD. Children with ADHD will be compared to a sample of sex and age-matched sample of
typically developing children.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborator:
Conselho Nacional de Desenvolvimento Científico e Tecnológico